Mrs Emily Greenwood Brown, WHNP | |
52 Christian Ridge Rd, Ellsworth, ME 04605-3210 | |
(207) 667-5304 | |
(207) 667-6117 |
Full Name | Mrs Emily Greenwood Brown |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Women's Health |
Location | 52 Christian Ridge Rd, Ellsworth, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669456208 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LW0102X | Nurse Practitioner - Women's Health | R041279 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Emily Greenwood Brown, WHNP 1091 Main St, Mount Desert, ME 04660-6320 Ph: (207) 244-7781 | Mrs Emily Greenwood Brown, WHNP 52 Christian Ridge Rd, Ellsworth, ME 04605-3210 Ph: (207) 667-5304 |
News Archive
Two new studies of progressive, neurodegenerative diseases linked to defects in cells' mitochondria offer hope for developing a new biomarker for research and diagnostics, and a drug for treating such diseases, report researchers at the University of California, Davis.
Infection with the hepatitis C virus is a contagious liver disease with symptoms that range from mild illness for a few weeks to serious, lifelong liver problems.
For nearly 40 years a class of drugs known as beta blockers have been proven to increase patients' survival prospects following a heart attack by decreasing the cardiac workload and oxygen demand on the heart. In a breakthrough study released in the American Heart Journal, Northwestern Medicine cardiologist Jeffrey J. Goldberger found the majority of patients are frequently not receiving a large enough dose of these drugs, which can put their recovery from heart attacks and overall health into peril.
Researchers from the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute, led by Dr. Àlex Vaquero, have proposed a new regulation mechanism of the NF-κB pathway, which is associated with accelerated cellular aging, based on the analysis of the function of the SirT6 protein.
Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration
› Verified 6 days ago
Mrs. Julie Ann Graham, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 35 Dollard Farm Way, Ellsworth, ME 04605 Phone: 248-921-3211 | |
Breanne Elizabeth Bisset, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 32 Resort Way, Ellsworth, ME 04605 Phone: 207-664-7800 | |
Mrs. Ruth Billings Tainter, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 34 Downeast Highway, Ellsworth, ME 04605 Phone: 207-667-2288 Fax: 207-667-6888 | |
Ms. Bethany L. Jarvis, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 248 State St, Suite 3a, Ellsworth, ME 04605 Phone: 207-812-7031 Fax: 207-660-4203 | |
Brittany Nurmukhamedov, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5650 | |
Roberta Sharp, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5340 Fax: 207-664-5338 | |
Michael Oneal, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5311 |